Swimmer Dara Torres Sports a White Upper Lip to Praise Milk as Her Post-Exercise Fitness Drink
Medal-Winning Mom 'Laps' Up Lowfat Milk to Help Keep Her Muscles and Bones in Top Shape WASHINGTON, April 8 /PRNewswire/ -- With summer on the horizon, millions of women have their sights on shedding bulky sweaters for swimsuits. Yet, award-winning swimmer and mom Dara Torres, 41, knows ther...Milkshakes are medicine for anorexic teens in family-based outpatient therapy
...egain the weight on his or her own. Nutritional rehabilitation gives the brain the nutrition it needs to re-establish healthy eating habits," says Dr. dara Bellace, a clinical psychologist at NewYork-Presbyterian Hospital/Westchester Division and an instructor of psychology in psychiatry at Weill Cornell ...Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease
...isease conventional treatment is not feasible, researchers say. Among the technical hurdles to improving blood flow in such patients, according to dara L. Kraitchman, V.M.D., Ph.D., associate professor of radiology at Johns Hopkins, is a means of telling doctors whether injected stem cells are staying...'Seeing' Stem Cells Helps in Fight Against Peripheral Arterial Disease
...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine . Transplanting stem cells derived from bone marrow (not emb...U-M Health Minute: Today's Top Health Issues and Medical Research
...ly represent the views of the Department of Veterans Affairs. Authors: In addition to Valenstein, authors of the paper were Hyungjin Myra Kim, dara Ganoczy, John F. McCarthy, Kara Zivin, Karen L. Austin, Katherine Hoggatt, Daniel Eisenberg, John D. Piette and Frederic C. Blow, all with affiliation...Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)
...14th, New Yorkers will receive their purchases in the limited edition bags. "We are very thankful to have the generous support of Duane Reade," said dara P. Richardson-Heron, MD, CEO of Komen Greater New York City. "In 2008, more than 170,000 people will be diagnosed with breast cancer and 40,000 will d...Rochester Medical Marketing VP Retires
...irstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM ) today announced dara Lynn Horner's retirement from the position of Vice President -- Marketing. ... a fine contributor, but Rochester Medical's loss will be the world's gain. dara Lynn will be very supportive of all our efforts through the transition and ...DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
... RALEIGH, N.C., April 16 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today that Surgi-Vision, Inc., a privately held company of which dara Biosciences owns approximately 9.8% of the outstan...Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
PS433540 Shown to Be Well Tolerated and Potentially Suited for Once Daily Administration PRINCETON, N.J., April 10, 2007 /PRNewswire-FirstCall/ -- Pharmacopeia , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Ph...Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
... Phase 2b Trial to Examine Safety and Efficacy of dara versus Active Control PRINCETON, N.J., March 3 /...433540 with irbesartan. "We are pleased with the dara program's rapid progress. This is our second Phase... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
...ensive patients, we are pleased to have the opportunity to demonstrate that dara can effectively lower blood pressure in this patient population." Results...ans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
... Company Also Provides Update on dara Program's Ongoing Phase 2a Hypertension Study P...ram, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect t...Pharmacopeia to Present at BIO CEO & Investor Conference 2008
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...Pharmacopeia Announces Third Quarter 2007 Financial Results
...macopeia Advances and Expands Internal Pipeline as dara Program Enters Phase 2 Clinical Development ...540, an unpartnered product candidate from its dara program, that is both an angiotensin receptor bloc... to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinic...'Seeing' stem cells helps in fight against peripheral arterial disease
...em cell treatments for PAD, we need suitable noninvasive methods to track the fate of stem cells clearly inside the body," said veterinary radiologist dara L. Kraitchman, V.M.D., Ph.D., an associate professor at Johns Hopkins School of Medicine. Transplanting stem cells derived from bone marrow (not embry...Magnetic probe successfully tracks implanted cells in cancer patients
...he Netherlands. "The cells can't get from the fat into the lymph nodes by themselves, so injecting them properly is very important." Bulte says he, dara Kraitchman, Ph.D., D.V.M., and colleagues at Hopkins are already testing magnetically labeled stem cells with MRI-compatible injection systems to allo...RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
...h was also previously with the R&D organization of the Janssen Research Foundation in Belgium. Dr. Cauwenbergh currently serves as a Board member of dara Biosciences, Upstream Biosciences as well as Ablynx NV, and is a member of the Board of Trustees, and Vice Chairman of Bio New Jersey. Since 2004, Dr....Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
... compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...Pharmacopeia Announces Management Team Changes
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...DARA BioSciences, Inc. Announces Appointment of New Director to Board
... RALEIGH, N.C., Feb. 27 /PRNewswire-FirstCall/ -- dara BioSciences(TM) (Nasdaq: dara ) announced today the appointment of Haywood D. Co... of seven other publicly-traded companies. About dara BioSciences, Inc. ...DARA BioSciences to Present at the ROTH Growth Stock Conference
... RALEIGH, N.C., Feb. 4 /PRNewswire/ -- dara BioSciences, Inc. today announced that the Company...on will be available at the same location. About dara BioSciences, Inc. dara BioSciences(TM), Inc. ("DARA") is a Raleigh, North...Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference
...atements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its dara program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmac...